Citation: | XIANGPing-ping, WANGXu, LIUChao. Discussion on Diabetes and the COVID-19 from the Perspective of Spleen Deficiency and Dampness Excess[J]. Journal of Nanjing University of traditional Chinese Medicine, 2020, 36(4): 531-533. |
[1] |
GUAN WJ, NI ZY, HU Y, et al. Clinical characteristics of coronavirus disease 2019 in China[J]. N Engl J Med, 2020, 382(18):1708-1720.
|
[2] |
WANG D, HU B, HU C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China[J]. JAMA, 2020, 323(11):1061-1069.
|
[3] |
WU H, LAU ESH, MA RCW, et al. Secular trends in all-cause and cause-specific mortality rates in people with diabetes in Hong Kong, 2001-2016: A retrospective cohort study[J]. Diabetologia, 2020, 63(4):757-766.
|
[4] |
KLEKOTKA RB, MIZGALA E, KROL W. The etiology of lower respiratory tract infections in people with diabetes[J]. Pneumonol Alergol Pol, 2015, 83(5):401-408.
|
[5] |
HUANG C, WANG Y, LI X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395(10223):497-506.
|
[6] |
ZHOU F, YU T, DU R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study[J]. Lancet, 2020, 395(10229):1054-1062.
|
[7] |
CHEN N, ZHOU M, DONG X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study[J]. Lancet, 2020, 395(10223):507-513.
|
[8] |
ALRADDADI BM, WATSON JT, ALMARASHI A, et al. Risk factors for primary middle east respiratory syndrome coronavirus illness in humans, saudi arabia, 2014[J]. Emerg Infect Dis, 2016, 22(1):49-55.
|
[9] |
YANG X, YU Y, XU J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study[J]. Lancet Respir Med, 2020, 8(5):475-481.
|
[10] |
DU Y, TU L, ZHU P, et al. Clinical features of 85 fatal cases of COVID-19 from Wuhan: A retrospective observational study[J]. Am J Respir Crit Care Med, 2020, 201(11):1372-1379.
|
[11] |
KLONOFF DC, UMPIERREZ GE. COVID-19 in patients with diabetes: Risk factors that increase morbidity[J]. Metabolism, 2020, 108:154224.
|
[12] |
GUO W, LI M, DONG Y, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19[J]. Diabetes Metab Res Rev, 2020,2020: e3319.
|
[13] |
张锡纯. 医学衷中参西录[M].石家庄:河北人民出版社,1957:158.
|
[14] |
张文佳,付晓乐,辛效毅.2型糖尿病中医证型与临床生化指标的关系[J].南京中医药大学学报,2017,33(5):484-487.
|
[15] |
灵枢经[M].北京:人民卫生出版社,2005:74.
|
[16] |
刘杰民,蔺晓源,王敏,等.基于肠道黏膜免疫的“脾为之卫”理论探讨[J]. 中国中医基础医学杂志, 2013, 19(4):460-466.
|
[17] |
张秉成.成方便读[M].北京:学苑出版社,2010:67-68.
|
[18] |
仝小林,李修洋,赵林华,等.从“寒湿疫”角度探讨新型冠状病毒肺炎的中医药防治策略[J].中医杂志,2020,61(6):465-470,553.
|
[19] |
周铭心.从五运六气辨识与防治新型冠状病毒肺炎[J].中医学报,2020,35(2):227-231.
|
[20] |
叶放,吴勉华,程海波,等.国医大师周仲瑛教授《新型冠状病毒肺炎中医辨治方案》解读[J]. 南京中医药大学学报, 2020, 36(2):141-144.
|
[21] |
张诗军, 吴伟康.湿证病机“蒙蔽性”特点初探[J]. 中国中医基础医学杂志, 2008, 14(7):486-487.
|
[22] |
黄帝内经素问[M].北京:人民卫生出版社,2005:45.
|
[23] |
李中梓.医宗必读[M].呼和浩特:内蒙古人民出版社,2006:212.
|